🚨 BREAKING $HIMS SEMAGLUTIDE PILL DOES *NOT* USE NOVO NORDISK'S PATENTED SNAC TECHNOLOGY - Novo owns SNAC, acquired Emisphere for $1.8B in 2020 specifically to control this delivery tech that makes oral peptides possible - SNAC enables stomach absorption. It protects the semaglutide from digestive enzymes and helps it cross the gut lining. Without it, oral peptides are ~impossible - Hims PR claims alternative delivery: pill is "formulated to protect the active ingredient during digestion and support absorption" using a different method